US venture capital investments by industry reveal that 21% belong to biotechnology. The industry has had the fastest growth for any major industry adding roughly 12% more jobs from 2000 to 2002. Generally, biotech companies are able to raise $10m to $30m in venture capital and are successfully floated during the exit. This is followed by a very positive image in the media: it?s almost impossible to read The Economist without seeing anything related to the great breakthrough …showed first 75 words of 1024 total…

…showed last 75 words of 1024 total… 2 decades at most. By that time someone has to succeed and provide great gains for certain investors and new ventures in other biotechnology branches. Yet this also means that it will result mostly in loses for everyone else in the same market segment. Therefore it can be considered as an industry with the highest risk levels But, unlike dotcoms, it assures long term progress as this is only possible through social value biotechnology provides.